Intima-media thickness in obese children before and after weight loss

Rainer Wunsch1, Gideon de Sousa, André Michael Toschke

  • 1Department of Pediatrics, University of Witten/Herdecke, Datteln, Germany.

Pediatrics
|December 5, 2006
PubMed

Insights

Childhood obesity is linked to early vascular changes. Weight loss in obese children significantly reduced intima-media thickness, indicating reversibility of these atherosclerotic changes.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Syndrome

Background:

  • Childhood obesity is associated with increased intima-media thickness (IMT), a marker of early atherosclerosis.
  • Obesity negatively impacts cardiovascular risk factors, including blood pressure, lipids, and insulin resistance.

Purpose of the Study:

  • To investigate the changes in intima-media thickness (IMT) in obese children following a weight loss intervention.
  • To assess the impact of weight loss on cardiovascular risk factors in prepubertal obese children.

Main Methods:

  • A 1-year outpatient intervention program was conducted on 56 prepubertal obese children.
  • Carotid intima-media thickness (cIMT) was measured using B-mode ultrasound.
  • Cardiovascular risk factors including blood pressure, lipids, glucose, insulin, and insulin resistance were analyzed.

Main Results:

  • Obese children exhibited significantly higher IMT and poorer cardiovascular risk profiles compared to non-obese controls.
  • Obese children who achieved substantial weight loss showed significant reductions in IMT, blood pressure, triglycerides, insulin, and insulin resistance.
  • High-density lipoprotein cholesterol levels increased significantly in obese children with substantial weight loss.

Conclusions:

  • Vascular changes, evidenced by increased IMT, occur early in childhood obesity.
  • Weight loss interventions can lead to the reversal of early atherosclerotic changes in obese children.
  • Improving cardiovascular risk factors through weight management is crucial for pediatric health.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...